{"id":"W2917694209","doi":"10.1212/wnl.0000000000007099","title":"Imaging outcome measures of neuroprotection and repair in MS","year":2019,"lang":"en","type":"review","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; St. Michael's Hospital","funders":"EMD Serono; Alberta Innovates; Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Multiple Sclerosis Society of Canada; Genentech; National Multiple Sclerosis Society; International Progressive MS Alliance; Acorda Therapeutics; Vertex Pharmaceuticals; Conrad N. Hilton Foundation; Wellcome Trust; Fondation Brain Canada; F. Hoffmann-La Roche; Pfizer; Biogen; Celgene; National Institutes of Health; Canadian Institutes of Health Research; Guthy-Jackson Charitable Foundation; Disarm Therapeutics; U.S. Department of Defense; Sanofi; Chugai Pharmaceutical; MedDay Pharmaceuticals; GlaxoSmithKline; Medical Research Council; Teva Pharmaceutical Industries","keywords":"Neuroprotection; Multiple sclerosis; Medicine; Clinical trial; Neuroscience; Intensive care medicine; Medical physics; Psychology; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01837906,0.0009203092,0.001538378,0.003249775,0.0003655139,0.001841633,0.0008040161,0.0007196523,0.001762511],"category_scores_gemma":[0.02811975,0.0001260568,0.001030796,0.002402188,0.001055724,0.001483573,0.0008959055,0.00124271,0.0002876444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001287263,"about_ca_system_score_gemma":0.001378421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000999724,"about_ca_topic_score_gemma":0.001812737,"domain_scores_codex":[0.9928584,0.00378101,0.0009538854,0.0005992309,0.001615647,0.0001918488],"domain_scores_gemma":[0.9828516,0.006600979,0.006854238,0.0004699586,0.002900123,0.0003231047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007665885,0.0004661858,0.1336093,0.03000246,0.006704876,0.0002986407,0.0009887768,0.002495495,0.003729723,0.009808599,0.01972906,0.784501],"study_design_scores_gemma":[0.001454732,0.0104478,0.7476935,0.03280359,0.01537935,0.003349432,0.002214967,0.006291084,0.01657033,0.03961086,0.1237527,0.0004317331],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1761216,0.7203304,0.03844667,0.02767216,0.002422052,0.001378256,0.007190681,0.0002640058,0.0261742],"genre_scores_gemma":[0.8188511,0.1413049,0.02660227,0.002387697,0.004256086,0.001590583,0.002660233,0.00007960566,0.00226755],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01837906,"threshold_uncertainty_score":0.09719896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2222122808611309,"score_gpt":0.4102756146866369,"score_spread":0.188063333825506,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}